GPhC: Pharmacies to ‘verify’ patient history before supplying hair loss drug

The pharmacy regulator has advised that pharmacy teams carry out a “robust” assessment before supplying finasteride – a hair-loss drug with psychiatric and sexual health risks.

Man worried about hair loss
“Providing finasteride at a distance carries particular risk"
Kate Bowie

Read more by Kate Bowie

Kate Bowie joined C+D as a digital reporter in August 2023 after graduating from a master’s in journalism at City, University of London. She began covering the primary care beat at the end of 2022, when she carried out several health investigations focused on staffing issues, NHS funding and health inequalities.

Latest from Regulation

More from Clinical